212 Tumor adjacent cytokine factories for eradication of ovarian cancer tumor burden in mice through cytotoxic T-cell activation with safe and predictable dosing in non-human primates

• Amir Jazaeri,
• Weiyi Peng,
• Chunyu Xu,
• Rahul Sheth,
• Andrea Hernandez,
• David Zhang,
• Amanda Nash,
• Maria Jarvis,
• Samira Aghlara-Fotovat,
• Sudip Mukherjee,
• Andrew Hecht,
• Peter Rios,
• Sofia Ghani,
• Ira Joshi,
• Douglas Isa,
• Yufei Cui,
• Shirin Nouraein,
• Jared Lee,
• Jose Oberholzer,
• Oleg Igoshin,
• Omid Veiseh

Affiliations

Amir Jazaeri

1 Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Weiyi Peng

Aff2 grid.240145.60000000122914776Melanoma Medical OncologyUniversity of Texas MD Anderson Cancer Center Houston TX USA

Chunyu Xu

Aff2 grid.240145.60000000122914776Melanoma Medical OncologyUniversity of Texas MD Anderson Cancer Center Houston TX USA

Rahul Sheth

MD Anderson Cancer Center, Houston, TX, USA

Andrea Hernandez

1Hospital Clínico Universidad de Chile

David Zhang

Medicine/PACC, Columbia University Irving Medical Center, New York, New York, USA

Amanda Nash

1Rice University, Houston, TX, USA

Maria Jarvis

1Rice University, Houston, TX, USA

Samira Aghlara-Fotovat

1Rice University, Houston, TX, USA

Sudip Mukherjee

1Rice University, Houston, TX, USA

Andrew Hecht

1Rice University, Houston, TX, USA

Peter Rios

2CellTrans Inc, Chicago, IL, USA

Sofia Ghani

2CellTrans Inc, Chicago, IL, USA

Ira Joshi

2CellTrans Inc, Chicago, IL, USA

Douglas Isa

2CellTrans Inc, Chicago, IL, USA

Yufei Cui

1Rice University, Houston, TX, USA

Shirin Nouraein

1Rice University, Houston, TX, USA

Jared Lee

1Rice University, Houston, TX, USA

Jose Oberholzer

2CellTrans Inc, Chicago, IL, USA

Oleg Igoshin

1Rice University, Houston, TX, USA

Omid Veiseh

1Rice University, Houston, TX, USA